EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

The muscle regeneration marker FOXP3 is associated with muscle injury in Duchenne muscular dystrophy

Sthephanie Yannin Hernández-de la Cruz, Thania Ordaz-Robles, Marco Antonio Villaldama-Soriano, Cristian Emmanuel Luna-Guzmán, Tomas Almeida-Becerril, Judith Villa-Morales, Alan Cárdenas-Conejo, Eugenia Dolores Ruíz-Cruz, Jorge Maldonado-Hernandez, Mariela Bernabe-Garcia, Lourdes Barbosa-Cortés, Maricela Rodríguez-Cruz

Brain and Development · 2024

DOI: 10.1016/j.braindev.2024.02.001 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Brain and Development, 2024. Verfasst von Sthephanie Yannin Hernández-de la Cruz und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Nutrición Molecular, Unidad de Investigación Médica en Nutrición, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto M…. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Instituto Mexicano del Seguro Social.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In Duchenne muscular dystrophy (DMD), the immune system cells (ISC) synthesize molecules to regulate inflammation, a process needed to regenerate muscle. The relationship between those molecules and the muscle injury is unknown. Monocytes belonging to ISC are regulated by omega-3 fatty acids (ω-3 LCPUFAs) in DMD, but whether those fatty acids influence other ISC like T-cells is unknown. OBJECTIVE: We analyzed the expression of the muscle regeneration markers (FOXP3 and AREG) in circulating leukocytes of DMD patients with different lower limb muscle functions and whether ω-3 LCPUFAs regulate the expression of those markers, and the populations of circulating T-cells, their intracellular cytokines, and disease progression (CD69 and CD49d) markers. METHODS: This placebo-controlled, double-blind, randomized study was conducted in DMD boys supplemented with ω-3 LCPUFAs (n = 18) or placebo (sunflower oil, n = 13) for six months. FOXP3 and AREG mRNA expression in leukocytes, immunophenotyping of T-cell populations, CD49d and CD69 markers, and intracellular cytokines in blood samples were analyzed at baseline and months 1, 2, 3, and 6 of supplementation. RESULTS: Patients with assisted ambulation expressed higher (P = 0.015) FOXP3 mRNA levels than ambulatory patients. The FOXP3 mRNA expression correlated (Rho = -0.526, P = 0.03) with the Vignos scale score at month six of supplementation with ω-3 LCPUFAs. CD49d + CD8 + T-cells population was lower (P = 0.037) in the ω -3 LCPUFAs group than placebo at month six of supplementation. CONCLUSION: FOXP3 is highly expressed in circulating leukocytes of DMD patients with the worst muscle function. Omega-3 LCPUFAs might modulate the synthesis of the adhesion marker CD49d + CD8 + T-cells, but their plausible impact on FOXP3 needs more research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneMaleHumansCytokinesMusclesForkhead Transcription FactorsRegenerationRNA, MessengerMuscle, Skeletal

Stichwörter der Autor:innen

AmphiregulinDuchenne muscular dystrophyForkhead box P3Muscle injuryOmega-3 long-chain polyunsaturated fatty acids

Substanzen

CytokinesForkhead Transcription FactorsRNA, MessengerFOXP3 protein, human

Autor:innen und Institutionen

  • Laboratorio de Nutrición Molecular, Unidad de Investigación Médica en Nutrición, Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de México (CDMX), Mexico. Ele…
  • Departamento de Genética Médica. Hospital de Pediatría, Centro Médico Nacional Siglo XXI, IMSS, CDMX, Mexico. Electronic address: alancardenasconejo@hotmail.com.
  • Departamento de Genética, UMAE Hospital General "Dr. Gaudencio González Garza". Centro Médico Nacional "La Raza", IMSS, CDMX, México. Electronic address: lolisruiz@hotmail.com.

Förderung

  • Instituto Mexicano del Seguro Social

Zitieren

APA

Yannin Hernández-de la Cruz, S., Ordaz-Robles, T., Antonio Villaldama-Soriano, M., Emmanuel Luna-Guzmán, C., Almeida-Becerril, T., Villa-Morales, J., Cárdenas-Conejo, A., Dolores Ruíz-Cruz, E., Maldonado-Hernandez, J., Bernabe-Garcia, M., Barbosa-Cortés, L., & Rodríguez-Cruz, M. (2024). The muscle regeneration marker FOXP3 is associated with muscle injury in Duchenne muscular dystrophy. Brain and Development. https://doi.org/10.1016/j.braindev.2024.02.001

Vancouver

Yannin Hernández-de la Cruz S, Ordaz-Robles T, Antonio Villaldama-Soriano M, Emmanuel Luna-Guzmán C, Almeida-Becerril T, Villa-Morales J, et al. The muscle regeneration marker FOXP3 is associated with muscle injury in Duchenne muscular dystrophy. Brain and Development. 2024. doi:10.1016/j.braindev.2024.02.001

BibTeX
@article{YanninHernndezdelaCruz2024,
  author = {Yannin Hernández-de la Cruz, Sthephanie and Ordaz-Robles, Thania and Antonio Villaldama-Soriano, Marco and Emmanuel Luna-Guzmán, Cristian and Almeida-Becerril, Tomas and Villa-Morales, Judith and Cárdenas-Conejo, Alan and Dolores Ruíz-Cruz, Eugenia and Maldonado-Hernandez, Jorge and Bernabe-Garcia, Mariela and Barbosa-Cortés, Lourdes and Rodríguez-Cruz, Maricela},
  title = {The muscle regeneration marker FOXP3 is associated with muscle injury in Duchenne muscular dystrophy},
  journal = {Brain and Development},
  year = {2024},
  doi = {10.1016/j.braindev.2024.02.001}
}
Kostenlos starten →